Home › NCT04824066
The Role of Wearable Devices in Predicting and Detecting Complications and Adverse Events
RecruitingObservational study
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: 1. Age 18 years or older 2. Individuals scheduled to undergo one of the following surgical or non-surgical treatments: cardiothoracic surgery, orthopedic surgery, vascular surgery, colorectal surgery, pancreatic surgery, other major abdominal surgeries, treatment for chronic disease, or systemic therapy (i.e., chemotherapy, immunotherapy, or targeted therapy), radiotherapy, or ablation. 3. Amenable to using one of the wearable devices of interest (Fitbit, iWatch, Biostrap). 4. Individuals willing to provide informed consent and who have capacity for all study procedures Exclusion Criteria: 1. Individuals with mental incapacity and/or cognitive impairment that would preclude adequate understanding of, or cooperation with the study protocol. 2. Any pregnant participant.
About the study
The overarching goal of this research is to use machine learning analysis of high-resolution data-collected by wearable technology-to predict complications and poor recovery in patients undergoing treatment for benign or malignant conditions.
What is being tested
- Device: Wearable Device (device)
Sponsor: Massachusetts General Hospital · Participants: 2,400 · Started: Jul 10, 2021
Contact the study team
- Chi-Fu Jeffrey Yang, MD · Phone: 617-726-5200
- Isha Mehta Warikoo, MD · Phone: 857-250-1355
Official record on ClinicalTrials.gov — NCT04824066
Locations in the U.S.
| Massachusetts | Massachusetts General Hospital, Boston |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.